Log in to search using one of your social media accounts:

 

Medical News Today: Pemphigoid: Symptoms, types, and treatment
Pemphigoid is rare autoimmune condition that can affect people of any age. What are the symptoms and what are the different types of pemphigoid? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 21, 2017 Category: Consumer Health News Tags: Dermatology Source Type: news

IgE Autoantibodies Tied to Disease Activity in Bullous Pemphigoid IgE Autoantibodies Tied to Disease Activity in Bullous Pemphigoid
In patients with bullous pemphigoid (BP), serum levels of IgE autoantibodies against transmembrane protein BP antigen 2 (BP180) appear to correlate with disease activity, according to German researchers.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - November 18, 2016 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Decision Support in Medicine: Bullous Pemphigoid
1. Are you confident of the diagnosis?What you should be alert for in the historyDetermine if the lesions are pruritic. Bullous pemphigoid (BP) is almost always pruritic, and itch can be the first presenting symptom or can herald a relapse.Ask about... (Source: Skin and Allergy News)
Source: Skin and Allergy News - September 21, 2016 Category: Dermatology Source Type: news

Bullous Pemphigoid
Title: Bullous PemphigoidCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/31/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 31, 2016 Category: Rheumatology Source Type: news

Poor outcome for PBC patient with bullous pemphigoid
A 45-year-old woman who was admitted with concurrent primary biliary cirrhosis or cholangitis (PBC) and bullous pemphigoid died 5 days after admittance, according to a case report from N.B. Guerra-Uribe, MD, and M.S. González-Huezo, MD. The patient was admitted to the emergency department for... (Source: Skin and Allergy News)
Source: Skin and Allergy News - June 29, 2016 Category: Dermatology Source Type: news

FDA accepts Immune's IND for bertilimumab to treat bullous pemphigoid
The US Food and Drug Administration (FDA) has accepted Immune Pharmaceuticals' investigational new drug (IND) application for its first in class, lead product candidate, bertilimumab, to treat Bullous Pemphigoid (BP). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 11, 2015 Category: Pharmaceuticals Source Type: news

Immune Pharmaceuticals Announces FDA Acceptance Of Investigational New Drug (IND) Application In The U.S. For Bertilimumab For The Treatment Of Bullous Pemphigoid
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ("Immune" or the "Company") announced today that the U.S. Food and Drug Administration (FDA) accepted the Company's Investigational New Drug (IND) application for its first in class, lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP). (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - November 10, 2015 Category: Pharmaceuticals Source Type: news

Your NEJM Group Today: Bullous Pemphigoid; Is It a Concussion?; Boston-Area Hospitalist Opportunities (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: Image in Clinical Medicine: … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 28, 2015 Category: Primary Care Source Type: news

Rare Skin Condition Tied to Linagliptin
(MedPage Today) -- Two cases of bullous pemphigoid with blisters and lesions (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 15, 2015 Category: Primary Care Source Type: news

Global Bullous Pemphigoid Clinical Trials Market H2 2014 in New...
This report provides elemental information and data relating to the clinical trials on Bullous...(PRWeb November 08, 2014)Read the full story at http://www.prweb.com/releases/global-bullous-pemphigoid/clinical-trials-market/prweb12310616.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 9, 2014 Category: Pharmaceuticals Source Type: news

Docs go to tech for needed advice
This story was produced in collaboration with  Long Island dermatologist Kavita Mariwalla knows well how to treat acne, burns and rashes. But when a patient came in with a potentially disfiguring case of bullous pemphigoid—a rare skin condition that causes large, watery blisters—she was stumped. read more (Source: Healthcare IT News)
Source: Healthcare IT News - June 2, 2014 Category: Information Technology Authors: Daniela Hernandez Tags: Online Only Business Intelligence Data Warehousing Electronic Health Records Source Type: news

These Factors May Predict Bullous Pemphigoid RelapseThese Factors May Predict Bullous Pemphigoid Relapse
Dr. Lipper reviews a study that looked for risk factors predictive of relapse during the first year of treatment. Medscape Dermatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 6, 2014 Category: Allergy & Immunology Tags: Dermatology Viewpoint Source Type: news

Clinical Challenges in the Diagnosis of Bullous PemphigoidClinical Challenges in the Diagnosis of Bullous Pemphigoid
The clinical presentation of bullous pemphigoid can be highly variable. In this review, the authors present a diagnostic algorithm highlighting available confirming immunopathological studies. Expert Review of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 29, 2013 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Scabies link with pemphigoid investigated
Research suggests that patients who experience scabies infection may be at increased risk for developing the autoimmune blistering skin condition bullous pemphigoid. (Source: MedWire News - Dermatology)
Source: MedWire News - Dermatology - March 22, 2013 Category: Dermatology Source Type: news

Bullous Pemphigoid
Title: Bullous PemphigoidCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/11/2013 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 11, 2013 Category: Rheumatology Source Type: news

Mouse Models of Autoimmune Blistering Diseases Induced by the Passive Transfer of Antibodies
Passive transfer of IgG into neonatal mice is a potential method of reproducing antibody-mediated blistering skin diseases. The major autoantigen for bullous pemphigoid is collagen XVII (COL17)/BP180, which is an epidermal linker transmembrane protein. A single intraperitoneal injection of human or rabbit IgG against pathogenic epitopes for COL17 can induce skin fragility in neonatal mice that express human COL17. Since amino acid sequences of the pathogenic epitopes for COL17 significantly differ between humans and rodents, the required antibodies are those that correctly target the molecule to induce the blistering pheno...
Source: Springer protocols feed by Molecular Medicine - December 19, 2012 Category: Molecular Biology Source Type: news